Коваленко В.Н., Несукай Е.Г. - Некоронарогенные болезни сердца. Практическое руководство.

ПоложенцевС.Д., Маклаков А.Г., ФедорецВ.Н., РудневД.А. Психологические особенности больных нейроциркуляторной дистонией // Кардиология. - 1995. - № 5. - С 70-72.

Преображенский Д. В., Сидоренко Б.А. Успехи и неудачи в разработке новых подходов к медикаментозной терапии хронической сердечной недостаточности. Часть 1. Кардиология. — 2000. — № 3. — С 52-60.

Преображенский Д.В., Сидоренко Б.А. Успехи и неудачи в разработке новых подходов к медикаментозной терапии хронической сердечной недостаточности. Часть 2. Кардиология. — 2000. - № 4. - С. 67— 76.

Преображенский Д.В., Савченко М.В., Киктев В.Г., Сидоренко Б.А. Фозиноприл — первый представитель нового поколения ингибиторов ангиотензинпревращающего фермента // Кардиология. — 2000. — № 5 — С 75-81.

Ребров А.П., Пономарева Е.Ю., Белова А.А., Кароли М.А. Инфекционный эндокардит: качество диагностики и клинические особенности // Терапевт, арх. — 2000. — № 9. — С 50-53.

Руднов В.А. Сепсис: современный взгляд на проблему// Клин, антимикробная химиотерапия. — 2000. — № 1. — С 4-Ю.

Симоненко В.Б., Бойцов С.А., Глухов А.А. Апоптоз и патология миокарда// Клин, медицина. — 2000. — № 8. — С 12-16.

Скворцов А.А., МареевВ.Ю., БеленковЮ.Н. Блокаторы рецепторов ан-гиотензина II (механизмы, первые клинические результаты) // Кардиология. - 1998. - № 4. - С 36-50.

Славина Л.С. Сердце при эндокринных заболеваниях. — М.: Медицина, 1979.-184с.

СпасокукоцкийА.Ю., Валько А.С. Инфекционный эндокардит. — К.: Здоров'я, 1983.— 95 с.

Сумароков А.В., Моисеев B.C., Шелепин А.А., Стяжкин В.Ю. Кардио-миопатии, миокардит, алкогольное поражение сердца // Терапевт, арх. — 1984.-№ 9.-С. 75-81.

Сучасне лікування хронічної серцевої недостатності: Метод, рекомендації/ Уклад. Л.Г. Воронков та ін. - К., 1998. — 28 с.

Тазина С.Я., Гуревич М.А. Современный инфекционный эндокардит (часть І) // Клин, медицина. - 1999. - № 12 - С. 19-23.

Тазина С.Я., Гуревич М.А. Современный инфекционный эндокардит (часть II) // Клин, медицина. — 2000. — № 1. — С. 15-20.

Терещенко С.Н.,ДжаианиН.А., Моисеев B.C. Генетические аспекты хронической сердечной недостаточности // Терапевт, арх. — 2000. — № 4. — С. 75-77.

Тюрин В.П. Глюкокортикоиды при инфекционном эндокардите: вред или польза? // Терапевт, арх. - 2000. - № 6. - С. 60-63.

Тюрин В.П., Дубинина СВ. Инфекционный эндокардит у лиц пожилого и старческого возраста// Клин, медицина. — 2000 — № 4. — С. 53—56.

Флоря В.Г., Мареев В.Ю., Самко А.Н. идр. Ремоделирование левого желудочка у пациентов с первичным поражением миокарда // Кардиология. — 1997.-№2-С. 10-15.

Хэгглин Р. Дифференциальная диагностика внутренних болезней. Пер. с нем./Под ред. Е.М. Тареева. — М.: Фирма «Миклош» и изд-во «Инженер», 1993.-794с.

Целуйко В.И., Максимова Н.А., Кравченко Н.А., Тарнакин А.Г. Генетический аспект гипертрофической кардиомиопатии// Кардиология. — 1998. — № 6. - С. 63-65.

Яковлев В.М., Карпов PC, Гасаненко Л.Н. Пролапс митрального клапана (этиология, клиника, лечение). — Томск: Изд-во Томского ун-та, 1985. — 188 с.

Abelmann W. Virus and the heart (review) // Circulation. — 1971. — Vol. 44, № 5. - P. 950-956.

Abraham WT, Bristow V.R. Specialized centers for heart failure management // Circulation. - 1997. - Vol. 96. - P. 2755-2757.

Abraham W, William T Mechanisms of disease: hormones and hemodynamics in heart failure // New Engl. J. Med. - 1999. - Vol. 341. - P. 577-585.

Adams J.E., Divila-RominV.G., BesseyP.Q.etal. Improved detection of cardiac contusion with cardiac troponin I//Amer. Heart J. — 1996. — Vol. 131. — P. 308.

Akamatsu H., Amano J., Sakamoto Т. etal. Primary chylopericardium// Ann. Thorac. Surg. - 1994. - Vol. 58. - P. 262.

Angelini A., Thiene G., Boffa G.M. et al. Endocardial biopsy in arrhythmogenic right ventricular cardiomyopathy // J. Amer. Coll. Cardiol. — 1993. — Vol. 21. — P. 259A.

Archard L.C., Bowles N.E., Cunningham L. etal. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value // Europ. Heart J.- 1991.-Vol. 12, Suppl. D. - P. 56-59.

Aretz H .T Myocarditis. The Dallas Criteria // Hum.Pathol. - 1987. - Vol. 18. -P. 619-624.

Aretz H.T., Billingham M.E., Edwards W.D. et al. Myocarditis: a histopathologic definition and classification //Amer. J. Cardiovasc. Pathol. — 1987. — Vol. 1. — P. 3-13.

Arsan S., Mercan S., Sarigl A. et al. Long-term experience with pericardiectomy: analysis of 105 consecutive patients //Thorac. Cardiovasc. Surg. — 1994.—Vol.42. — P. 340.

AuffermannW.,WichterT, BreithardtG. etal. Arrhythmogenic right ventricular disease: MR imaging versus angiography //Amer. J. Radiol. — 1993. — Vol. 161. — P. 549-555.

Aukrust P., Ueland T, Lien E. et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy // Amer. J. Cardiol. — 1999.-Vol. 83.-P. 376-382.

Auten G.M., Del Bene V. Endocarditis: current guidelines on prophylaxis, diagnosis and treatment//Consultant. — 1996. — № 5. — P. 973-993.

Avierinos J. F., Mohty D. M., Sarano M. E. Determinants of mitral valve prolapse prognosis in a large population based sample//Europ. Heart J. — 2000. —Vol. 21, Abstr. Suppl. - P. 303.

Awan N.A., Mason D.T Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure // Amer. Heart J. - 1996. -Vol. 131. - P. 177-185.

Azizi M., ChatelierG., GuyeneT. etal. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives//Circulation. — 1995. — Vol. 92. — P. 825-834.

Ball A.M., Sole M.J. Oxidative stress and the pathogenesis of heart failure// Cardiol. Clin. - 1998. - Vol. 16. - P. 665-675.

Bardales R.H., Stanley M.W., Schaefer R.F. et al. Secondary pericardia] malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis //Amer. J. Clin. Pathol. - 1996. - Vol. 106. - P. 29.

Bayer A. S. Revised diagnostic criteria for infective endocarditis // Cardiol. Clin. — 1996.-Vol. 14.-P. 345-350.

Blake L.M., Scheinman M.M., Higgins C.B. MR features of arrhythmogenic right ventricular dysplasia// Amer. J. Radiol. - 1994. - Vol. 162. - P. 809-812.

Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management // Ann. Intern. Med. — 1992. - Vol. 117, № 6. - P. 502-510.

Booz G.W., Baker K.M. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy // Hypertension. — 1996. — Vol. 28. - P. 635-640.

Bostman L.A., Salo J.A., Bostman O.M. Stab wounds to the pericardium and heart: an analysis of 85 consecutive patients// Europ. J. Surg. — 1992. — Vol. 158. — P. 271.

Bouhour J.B., Helias J., deLajartre A.Y. et al. Detection of myocarditis during the first year after discovery of a dilated cardiomyopathy by endomyocardial biopsy and gallium-67 myocardial scintigraphy: prospective multicentre French study of 91 patients // Europ. Heart J. - 1988. - Vol. 9. - P. 520-528.

Brandt R.R., FilzmaierK., JanssensU. etal. Increases of cardiac troponin I compared to creatin kinase in acute pericarditis // J. Amer. Coll. Cardiol. — 2000. — Vol.35, issue 2, Suppl. A. - P. 226.

Braunwald E. Heart failure.—Harrison's Principles of Internal Medicine— 13lh edition. McGraw-Hill, NY, 1994. - P. 998-1008.

Braunwald E. Heart disease/W.B.Saunders. Philadelphia, 3nd edition, 1995. — 1124p.

Braunwald E. Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities // New Engl. J. Med. — 1997. — Vol. 337. — P. 1360-1369.

BreithardtG., WichterT, Haverkamp W etal. Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy? Long QT syndrome or no structural heart disease //Amer. Heart J.— 1994.—Vol. 127, Suppl. — P. 1151-1158.

Brown J., MacKinnon D., King A. et al. Elevated arterial blood pressure in cardiac tamponade // New Engl. J. Med. - 1992. - Vol. 327. - P. 463.

Brown M., Griffin G.E. Immune responces in endocarditis//Heart. — 1998. — Vol. 79. - P. 1-2.

Cai J., Jones D.P. Superoxide in apoptosis//J. Biol. Chem. — 1998. — Vol. 273. — P 11401-11404.

Califf R.M. Beta-blocker therapy for heart failure // J. A. M. A. - 2000. -Vol. 283, №10.-P. 1335-1337.

Carrasco H.A., Vicuna A.V., Molina C. et al. Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage // Int. J. Cardiol. — 1985. — Vol. 9. — P. 425-428.

Castells E., Ferran V, Octavio de Toledo M.C. et al. Cardiac myxomas: surgical treatment, long-term results and recurrence//J. Cardiovasc. Surg. — 1993. — Vol. 34. _ R 49.

CharronPh., TessonR, PoirierO.etal. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy//Europ. Heart J. — 1999. —Vol.20. — P. 1587-1591.

Chojnowska L., Ruzyllo W. Rodzinna kardiomiopatia przerostowa // Kardiol. Pol. - 2000. - Vol. 53, Suppl. III. - P. 88-95.

ChowL.H., BeiselK.W, McManusB.M. Enteroviral infection of mice with severe combined immunodeficiency: evidence for direct viral pathogenesis of myocardial injury // Lab. Invest. - 1992. - Vol. 66. - P. 24-31.

Cleveland J.L., Ihle J.N. Contenders in Fas/TNF cell signalling //Cell. - 1998. -Vol. 81.-P. 479-482.

Cohen G.M. Caspases: the executioners of apoptosis//Biochem. J. — 1998. — Vol. 326.-P. 1-16.

Collier RE., Goodman G.B. Cardiac tamponade caused by central venous catheter perforation of the heart: a preventable complication //J. Am. Coll. Surg. — 1995.-Vol. 181.-P. 459.

CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure//New Engl. J. Med. — 1987. - Vol. 316. - P. 1429-1435.

CookS.A., Poole-Wilson P.A. Cardiac myocyte apoptosis//Europ. Heart J. — 1999. - Vol. 20. - P. 1619-1629.

Cowburn P.J., Cleland J.Y.F., Coats A.J.S. et al. Risk stratification in chronic heart failure // Europ. Heart J. - 1998. - Vol. 19. - P. 696-710.

Cowie M, R., Mosterd A., Wbod A. et al. The epidemiology of heart failure // Europ. Heart J. - 1997. - Vol. 18. - P. 208-225.

Craighead J.E., Huber S.A., Martin W.B. Murine cytomegalovirus // Europ. Heart J.- 1991.-Vol. 12 (Suppl. D). - P. 69-72.

Crozier I., Ikram H., Awan N. et al. Losartan in heart failure: Hemodynamic effects and tolerability//Circulation. — 1995. - Vol. 95, № 3. - P. 691-697.

Dabrowska-Kugacka A., Lubinski A., Baczynska A. etal. Influence of structural abnormalities on dispersion of cardiac repolarisation in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy// Kardiol. Pol. — 2000. — Vol. 53. — P. 482-486.

Daliento L., RizzoliC.,ThieneG. etal. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy // Amer. J. Cardiol. — 1990. - Vol. 60. - P. 741-745.

Daubert J.C., Descaves C, Foulgoc J.L. et al. Critical analysis of cineangiographic criteria for diagnosis of arrhythmogenic right ventricular dysplasia // Amer. Heart J. - 1988. - Vol. 115. - P. 448-459.

DecG.M., FusterV. Idiopathic dilated cardiomyopathy//New Engl. J. Med. — 1994. - Vol. 331. - P. 1564-1575.

Dembinska-Kiec A. Rola cytokin w patomechanizmie niewydolnosci serca // Kar-dioLPol. - 2000. - Vol. 53, Suppl. III. - P. 70-75.

Dickstein K., Chang P., Willenheimer R. et al. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure // J. Amer. Coll. Cardiol. — 1995. — Vol. 26.-P. 438-445.

Dougherty A. H. Congestive heart failure with normal systolic function // Amer. J. Cardiol. - 1984. - Vol. 54. - P. 778-782.

DurackD.T., Bright D.K., Lukes A.S. Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis //Amer. J. Med. — 1994. —Vol.96. — P. 200-209.

Dutka D.P., Elborn J.S., Delamere F. et al. Tumour necrosis factoralpha in severe congestive cardiac failure//Brit. Heart J. — 1993.—Vol. 70. — P. 141-143.

Eriksson H. Heart failure: agrowing public health problem//J. Intern. Med. — 1995. -Vol. 237. -P. 135-141.

Espinosa R., Carrasco H.A., Belandria F. et al. Life expectancy analysis in patients with Сhagas disease. Prognosis after one decade (1973-1983)//Int. J. Cardiol. — 1985.-Vol. 8.-P. 45-48.

Evan G., Littlewood X A matter of life and cell death // Science. — 1998. -Vol. 281.-P. 1317-1321.

Feeley K. Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry//J. Clin. Pathol. - 2000. - Vol. 53, № 2. - P. 147-149.

Feneley M.P. HIV-related cardiovascular disease // Med. J. Aust. — 1996. — Vol. 164.-P. 482.

Ferrari R. Tumor necrosis factor in chronic heart failure: a double facet cytokine // Cardiovasc. Res. - 1998. - \fol. 37. - P. 554-559.

Ferrari R., Bachetti Т., Agnoletti L. et al. Endothelial function and dysfunction in heart failure//Europ. Heart J.- 1998.-Vol. 19, Suppl. G. - P. 41-47.

Ferrari R. Origin of heart failure: cardiac or generalized myopathy? // Europ. Heart J. - 1999. - Vol. 20. - P. 1613-1614.

Feuerstein G., Bril A., Ruffolo R. Protective effects of carvedilol in the myocardium//Amer. J. Cardiol. - 1997. - Vol. 80. - P. 41-45.

Figueroa W., Alankar S., Pai N. et al. Subxiphoid pericardial window for pericardial effusion in end-stage renal disease // Amer. J. Kidney Dis. — 1996. — Vol. 27.-P. 664.

Filipiak K.J., Tarchalska-Krynska В., Opolski F. Metaloproteinazy i ich udzial w przebudowie miesnia sercowego // Kardiol. Pol. — 2000. — Vol. 53, Suppl. III. — P. 83-87.

Fowler N.O. Cardiac tamponade: a clinical or an echocardiographic diagnosis? (editorial)//Circulation. - 1993. - Vol. 87. - P. 1738.

Fowler N.O. Constrictive pericarditis: its history and current status // Clin. Cardiol.- 1995.-Vol. 18.-P. 341.

Friedrich S.P. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis // Circulation. - 1991. - Vol. 90, № 6. - P. 2761-2771.

Friman G. Myocarditis. Epidemiology, etiology and clinical aspects // Europ. Heart J. - 1995. - Vol. 16. - P. 173-175.

FuldaG., Rodriguez A., Turney S.Z. etal. Blunt traumatic pericardial rupture: a ten-year experience, 1979 to 1989 // J. Cardiovasc. Surg. - 1990. - Vol. 31. -P. 525.

Gaasch W.H. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction // JAMA. - 1994. - Vol. 271, № 16. - P. 1276-1280.

Gandhi S.K., Marts B.C., MistryB.M. etal. Selective management ofembolized intracardiac missiles//Ann. Thorac. Surg.- 1996. - Vol. 62. - P. 290.

Garcia M.J., Rodriguez L., Ares M. et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging // J. Amen Coll. Cardiol. — 1996.-Vol.27.-P. 108.

Gavras I. Bradykinin-mediated effects of ACE inhibition //Kidney Int. — 1992. — Vol. 42.-P. 1020-1029.

Gottlieb S,S., Dickstein K., Fleck E. et al. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure // Circulation. - 1993. - \fol. 88. - P. 1602-1609.

Granville D.J., Carthy СМ., Hunt D.W.C. etal. Apoptosis: molecular aspects of cell death and disease// Lab.Invest. - 1998. - Vol. 78. - P. 893-913.

Graupner C, Vilacosta I., San Roman J.A. et al. Risk of embolization after institution of antibiotic therapy in endocarditis //Europ. Heart J. — 2000. —Vol. 21, Abstr. Suppl. — P. 304.

Graupner C, Vilacosta L, Fernandez C. et al. Echocardiographic prognostic indicators in infective endocarditis // Europ. Heart J. — 2000. — Vol. 21, Abstr. Suppl. - P. 692.

Green D.R., ReedJ.C. Mitochondria and apoptosis//Science. — 1998. —Vol. 281.-P. 1309-1312.

Grossman W. Diastolic dysfunction in congestive heart failure // New Engl. J. Med.- 1991.-Vol. 325, №22. - P. 1557-1564.

Gullestad L., Aass H., Fjeld J. et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure // Circulation. — 2001. — Vol. 103.-P. 220-225.

HajjarR.J., RoseG.A., Madsen J.C. etal. Extrapericardial cardiac tamponade after blunt chest trauma (pt I)//Amer. Heart J.— 1995. — Vol. 130. — P. 620.

HamrellB.B., Huber S.A., Leslie K.O. Reduced unloaded sarcomere shortening velocity and a shift to a slower myosin isoform in acute murine coxsackievirus myocarditis // Circulation Res. - 1994. - Vol. 75, № 3. - P. 462—472.

Hancock E.W. On the elastic and rigid forms of constrictive pericarditis // Amer. Heart J.- 1980.-Vol. 100.-P. 917.

Hancock E.W. Subacute effusive-constrictive pericarditis // Circulation. — I971.-Vol.43.-P. 183.

Hayashida W. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: Modification by long-term enalapril treatment //J. Amer. Coll. Cardiol. - 1993. - Vol. 22, № 5. - P. 1403-1410.

Hazelrigg S.R., Mack M.J., Landreneau R.J. etal. Thoracoscopicpericardiectomy for effusive pericardial disease//Ann. Thorac. Surg. — 1993. — Vol. 56. — P. 792. Heart disease/Ed. E. Braunwald.- W.B. Saunders Company, 1988. - P. 1410— 1469.

Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effect of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients // New Engl. J. Med. - 2000. - Vol. 342. - P. 145-153.

Hengstenberg C, Maisch B. Neue aspekte in derdiagnostik entzundlicherund dilatativer herzmuskelerkrankungen // Herz Kreisl. — 1992. — Vol. 24, № 6. — P. 179-183.

Herrera-Ganza E.H., Stetson S.J., Cubillos-Garzon A. et al. Tumor necrosis factor-a. A mediator of disease progression in the failing human heart // Chest. — 1999- - Vol. 115. - P. 1170-1174.

Herskowitz A., Ahmed-Ansari A. Myocarditis // Curr. Opinion in Cardiology. — 1992. - Vol. 7, № 3. - P. 469-475.

Hersum M., Maisch B. Humoral and cellular immune reactions to the myocardium in myocarditis // Herz. — 1992. — Vol. 17, № 2. - P. 91-96.

Hilgenberg A.D., Logan D.L., Akins C.W. et al. Blunt injuries of the thoracic aorta//Ann. Thorac. Surg. - 1992.- Vol. 53. - P. 233.

Hjalmarson A., Goldstein S., Fagenberg B. et al. Effects of controlled-release metoprolol on total mortality, hospitalization and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) //JAMA. - 2000. - Vol. 283, № 10. - P. 1295-1302.

Ho K.K.L.,.Anderson K.M., Kannel W.B. et al. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects // Circulation. — 1993.-Vol. 88.-P. 107-115.

Ho K.K.L., Pinsky J.L., Kannel W.B. etal. The epidemiology of heart failure: The Framingham Study//J. Amer. Coll. Cardiol. - 1993. - Vol. 22 (Suppl. A). -P6A-13A.

Hofling K., Tracy S. Expression of an antigenic adenovirus epitope in agroup В coxsackievirus //J. Virol. - 2000. - V. 74, № 10. - P. 4570-4578.

Hornig В., Arakawa A., Huber S.A. Viral myocarditis: a tale of two diseases // Lab. Invest. - 1992. - Vol. вв. - P. 1-3.

Houghton J.L. Pericarditis and myocarditis: which is benign and which isn't? // Postgrad. Med. - 1992. - Vol. 91, № 2. - P. 273-278, 281-282.